SCHEMBL30245122

SCHEMBL30245122

COc1cccc(CN(Cc2cccc(N(C)C)c2)c2cccc(COCCOCCOCc3ccccc3)c2)c1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CETP P11597 3/20 0.47
▸ CALM1 P0DP23 1/20 0.45
▸ CAMKK2 Q96RR4 1/20 0.45
▸ QPCT Q16769 2/20 0.45
▸ MTNR1A P48039 1/20 0.44
▸ MTNR1B P49286 1/20 0.44
▸ MAOB P27338 1/20 0.44
▸ IDO1 P14902 2/20 0.42
▸ AGXT P21549 2/20 0.42
▸ CHRM3 P20309 2/20 0.40
▸ NR3C1 P04150 1/20 0.40
▸ ABCB1 P08183 1/20 0.39
▸ HTR1A P08908 1/20 0.39
▸ DRD2 P14416 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ BCHE P06276 1/20 0.39
▸ APP P05067 1/20 0.39
▸ AOC3 Q16853 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30245930 0.96 QPCT (0.47) CETPCALM1CAMKK2QPCTMTNR1A
SCHEMBL30245690 0.95 CETP (0.50) CETPCALM1CAMKK2QPCTMTNR1A
SCHEMBL30244988 0.95 QPCT (0.48) CETPCALM1CAMKK2QPCTMTNR1A
SCHEMBL30245228 0.94 CALM1 (0.44) CETPCALM1CAMKK2QPCTMTNR1A
SCHEMBL25424604 0.93 CETP (0.46) CETPCALM1CAMKK2QPCTMTNR1A
SCHEMBL30245313 0.93 CETP (0.46) CETPCALM1CAMKK2QPCTMTNR1A
SCHEMBL30245702 0.93 QPCT (0.45) CETPCALM1CAMKK2QPCTMAOB
SCHEMBL30245848 0.92 QPCT (0.46) CETPCALM1CAMKK2QPCTMAOB
SCHEMBL30245465 0.92 QPCT (0.51) CETPCALM1CAMKK2QPCTMTNR1A
SCHEMBL30245212 0.91 ALDH1A1 (0.47) CETPQPCTMAOBIDO1AGXT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4384516-A1 AMINOARYL-INTEGRIN AGONISTS COMPOUNDS Texas Heart Institute (US) 2024-06-19 — — EP claimed
WO-2023018472-A9 AMINOARYL-INTEGRIN AGONISTS COMPOUNDS TEXAS HEART INSTITUTE (US) 2023-07-13 — — WO claimed
WO-2023018472-A1 AMINOARYL-INTEGRIN AGONISTS COMPOUNDS TEXAS HEART INSTITUTE (US) 2023-02-16 — — WO claimed
EP-4384516-A1 AMINOARYL-INTEGRIN AGONISTS COMPOUNDS Texas Heart Institute (US) 2024-06-19 — — EP disclosed
WO-2023018472-A9 AMINOARYL-INTEGRIN AGONISTS COMPOUNDS TEXAS HEART INSTITUTE (US) 2023-07-13 — — WO disclosed
WO-2023018472-A1 AMINOARYL-INTEGRIN AGONISTS COMPOUNDS TEXAS HEART INSTITUTE (US) 2023-02-16 — — WO disclosed
Send feedback